Strata Skin Sciences, Inc.
SSKN Healthcare Medical Devices
Strata Skin Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $30.7 million, down 8.54% from fiscal 2024. In the quarter to December 2025, revenue fell 2.97%, EPS grew 111.5%, free cash flow fell 376.9% and total debt rose 1.03%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow SSKN
Strata Skin Sciences, Inc. (SSKN) Altman Z-score
Strata Skin Sciences, Inc.'s Altman Z-score for fiscal 2025 is −11.48, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | −11.48 | (1.95) |
| FY2024 | −9.53 | (1.85) |
| FY2023 | −7.68 | (2.08) |
| FY2022 | −5.60 | 0.41 |
| FY2021 | −6.00 | 0.05 |
| FY2020 | −6.05 | (0.53) |
| FY2019 | −5.52 | (0.26) |
| FY2018 | −5.26 | 1.36 |
| FY2017 | −6.62 | (0.37) |
| FY2016 | −6.25 | 0.12 |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | (0.37) | — | −0.44 | |
| Retained earnings / total assets | (8.34) | — | −11.67 | |
| EBIT / total assets | (0.15) | — | −0.51 | |
| Market value of equity / total liabilities | 0.21 | — | 0.13 | |
| Sales / total assets | 1.01 | — | 1.01 | |
| Altman Z-score | Distress zone | −11.48 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −30.49 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| DHAI DIH Holding US, Inc. compare | −1.8× |
| DYNTQ Dynatronics Corporation compare | −2.3× |
| FEED ENvue Medical, Inc. compare | −4.7× |
| SSKN Strata Skin Sciences, Inc. | −11.5× |
| AFIB Acutus Medical, Inc. compare | −28.5× |
| VJET Flyte Aviation, Inc. compare | −30.6× |
| THMO ThermoGenesis Holdings, Inc. compare | −37.8× |
| NUWE Nuwellis, Inc. compare | −76.4× |
| PFSA PROFUSA, Inc. compare | −83.9× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets